Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4116 |  OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4119 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.00 USD | -3.68% | -12.35% | -4.68% | 0.00% | 56.13 M USD | ||
| 4120 |  GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD | ||
| 4126 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.88 USD | -6.38% | -10.20% | -55.78% | -56.00% | 55.42 M USD | ||
| 4139 |  LONA LeonaBio, Inc. - Common Stock | 5.75 USD | -1.37% | +32.49% | -27.22% | -14.69% | 54.17 M USD | ||
| 4141 |  ACET Adicet Bio, Inc. - Common Stock | 5.74 USD | -7.12% | -14.33% | -39.32% | +523.91% | 53.73 M USD | ||
| 4151 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.37 USD | -6.13% | -12.69% | -6.39% | -62.13% | 52.37 M USD | ||
| 4155 |  DOMH Dominari Holdings Inc. - Common Stock | 2.15 USD | -0.46% | +2.38% | +11.40% | -65.82% | 52.12 M USD | ||
| 4156 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | 0.00% | +1.35% | +0.67% | +947.67% | 52.10 M USD | ||
| 4161 |  CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 USD | -22.58% | -61.29% | -66.20% | -82.61% | 51.46 M USD | ||
| 4168 |  SER Serina Therapeutics, Inc. Common Stock | 2.00 USD | -0.99% | +0.50% | -27.01% | +19.76% | 50.80 M USD | ||
| 4169 |  INMB INmune Bio Inc. - Common stock | 1.83 USD | -1.61% | -5.67% | -24.69% | -7.58% | 50.79 M USD | ||
| 4172 |  ANVS Annovis Bio, Inc. Common Stock | 1.18 USD | -1.67% | -0.84% | -2.48% | -27.16% | 50.28 M USD | ||
| 4178 |  CRVO CervoMed Inc. - Common Stock | 3.28 USD | +3.14% | +10.81% | +31.20% | -61.82% | 49.59 M USD | ||
| 4194 |  APLM Apollomics Inc. - Class A Ordinary Shares | 21.70 USD | +0.93% | -7.66% | -9.21% | +17.93% | 47.65 M USD | ||
| 4196 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 1.81 USD | -2.16% | -7.65% | -23.63% | -81.90% | 47.57 M USD | ||
| 4199 |  CELU Celularity Inc. - Class A Common Stock | 1.46 USD | -0.68% | +2.10% | +1.39% | -32.09% | 47.38 M USD | ||
| 4203 |  IMA ImageneBio, Inc. - Common Stock | 4.12 USD | -10.63% | -10.04% | -15.40% | -50.54% | 46.77 M USD | ||
| 4211 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.06 USD | +8.78% | +7.13% | -2.75% | +854.05% | 45.97 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |